HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review

HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review

T-cell mediated drug hypersensitivity reactions may range from mild rash to severe fatal reactions. Among them, drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS), Stevens-Johnson syndrome/ toxic epidermal necrolysis (SJS/TEN), are some of...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Chi-Yuan Cheng, Shih-Chi Su, Chi-Hua Chen, Wei-Li Chen, Shin-Tarng Deng, Wen-Hung Chung
Format:	Artykuł
Język:	English
Wydane:	Hindawi Limited 2014-01-01
Seria:	Journal of Immunology Research
Dostęp online:	http://dx.doi.org/10.1155/2014/565320

Podobne zapisy

HLA Association with Drug-Induced Adverse Reactions
od: Wen-Lang Fan, i wsp.
Wydane: (2017-01-01)

Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity
od: Haiqin Jiang, i wsp.
Wydane: (2022-08-01)

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
od: Chun-Bing Chen, i wsp.
Wydane: (2018-01-01)

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
od: Luis González-Aveledo, i wsp.
Wydane: (2010-01-01)

Erratum to “An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity”
od: Chun-Bing Chen, i wsp.
Wydane: (2019-01-01)

Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
od: Mu-Tzu Chu, i wsp.
Wydane: (2023-01-01)

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis
od: Lisanne E. N. Manson, i wsp.
Wydane: (2021-12-01)

Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review
od: Chun-Bing Chen, i wsp.
Wydane: (2023-01-01)

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
od: Lisanne E. N. Manson, i wsp.
Wydane: (2023-10-01)

Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
od: Chun-Bing Chen, i wsp.
Wydane: (2023-06-01)

HLA alleles associated with asparaginase hypersensitivity in Chinese children
od: Gilbert T. Chua, i wsp.
Wydane: (2021-10-01)

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
od: Chih-Hsuan Wung, i wsp.
Wydane: (2023-04-01)

Hypersensitivity reactions to small molecule drugs
od: Jiayin Han, i wsp.
Wydane: (2022-11-01)

Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis
od: Shih-Chi Su, i wsp.
Wydane: (2013-12-01)

Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions
od: Hung-Chih Hsu, i wsp.
Wydane: (2024-10-01)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
od: Lisanne E. N. Manson, i wsp.
Wydane: (2020-09-01)

Associations of HLA-A and HLA-B with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population
od: Chuang-Wei Wang, i wsp.
Wydane: (2022-11-01)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
od: Shih-Chi Su, i wsp.
Wydane: (2014-01-01)

Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions
od: Pedro Ayuso, i wsp.
Wydane: (2021-02-01)

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019
od: Tetsuo Shiohara, i wsp.
Wydane: (2019-07-01)

The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity
od: Yun-Shiuan Olivia Hsu, i wsp.
Wydane: (2021-02-01)

Genetic Susceptibility of <i>HLA</i> Alleles to Non-Steroidal Anti-Inflammatory Drug Hypersensitivity in the Taiwanese Population
od: Szu-Ling Chang, i wsp.
Wydane: (2023-12-01)

Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions
od: James Line, i wsp.
Wydane: (2023-09-01)

Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions
od: Yueran Li, i wsp.
Wydane: (2021-04-01)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
od: Ana Copaescu, i wsp.
Wydane: (2021-01-01)

Risk factors for drug hypersensitivity reactions in children
od: Francesca Mori, i wsp.
Wydane: (2024-07-01)

Drug hypersensitivity reactions and allergy in patients with mastocytosis
od: Justyna H. Czarny, i wsp.
Wydane: (2017-03-01)

Pharmacogenetics and predictive testing of drug hypersensitivity reactions
od: Ruwen Boehm, i wsp.
Wydane: (2016-10-01)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
od: Gwendolin S. Simper, i wsp.
Wydane: (2019-10-01)

Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment
od: Ashley Vander Does, i wsp.
Wydane: (2022-09-01)

Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions
od: Rasol Molatefi, i wsp.
Wydane: (2024-07-01)

New Advances in Drug Hypersensitivity Research and Treatment
od: Yi-Giien Tsai, i wsp.
Wydane: (2018-01-01)

Vaccine hypersensitivity - update and overview
od: PJ Fritsche
Wydane: (2010-05-01)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
od: Mohitosh Biswas, i wsp.
Wydane: (2022-08-01)

Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
od: Sung-Yoon Kang, i wsp.
Wydane: (2021-03-01)

Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis
od: Wimonchat Tangamornsuksan, i wsp.
Wydane: (2015-02-01)

Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80
od: Ester Mohedano, i wsp.
Wydane: (2018-01-01)

Distribution of HLA-B Alleles and Haplotypes in Qatari: Recommendation for Establishing Pharmacogenomic Markers Screening for Drug Hypersensitivity
od: Mohammed Dashti, i wsp.
Wydane: (2022-08-01)

HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity
od: So-Young Park, MD, PhD, i wsp.
Wydane: (2024-05-01)

The influence of HLA genotype on the development of metal hypersensitivity following joint replacement
od: David J. Langton, i wsp.
Wydane: (2022-06-01)